Phase III MATTERHORN trial data show a statistically significant and clinically meaningful improvement in event-free survival for patients with resectable gastric and gastroesophageal junction cancer ...
The last few weeks are pointing to clear directional markets in the coming weeks, months and probably years. Stocks have peaked. Gold and Silver have resumed a secular uptrend. (price targets later in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback